 Presentation and QA session scheduled for post-market on Monday, March 28, 2022 BOSTON , March 17, 2022 PRNewswire -- Ginkgo Bioworks NYSE: DNA, the leading horizontal platform for cell programming, announced today that it plans to host a presentation and QA session reviewing business performance for the fourth quarter and full year ended December 31, 2021, on Monday, March 28, 2022, beginning at 4:30 p.m. ET. The presentation details and webcast registration link will be available on Ginkgos investor relations website at and a replay will be made available. 